CELLIVITY is available to adults only. Supplement pages are general product information; peptide records are not a sales offer and are not for human use.
Age confirmation is a declaration, not identity verification. Restricted research access still requires separate professional eligibility checks.Privacy and legal notice ↗
Tirzepatide is a synthetic, long-acting peptide that activates both GIP and GLP-1 receptors. Authorised tirzepatide medicines have been studied in large clinical programmes for defined metabolic indications; a catalogue vial does not automatically match an authorised finished medicine.
Research focus
Dual GIP and GLP-1 receptor signalling in defined metabolic settings.
Current evidence context
Randomised clinical evidence supports authorised tirzepatide medicines for their labelled indications. It does not establish a general anti-ageing effect, and it cannot be transferred to an unverified bulk or catalogue presentation.
Questions this record follows
How much does each receptor contribute to measured metabolic effects?
How durable are changes in validated metabolic and body-composition markers?
Which longer-term safety signals matter in defined patient populations?
Follow the sources
Registry entries identify reference substances. Literature links describe research and do not certify this product or its batch.
Exact CELLIVITY-batch review is pending. Reference files below describe their own declared samples.
Purity, identity, per-vial content and sterility are separate results.
Product
Tirzepatide
Record
CEL-P-TIR-001
Files received
0
0 FILES
No product-specific laboratory file has been uploaded yet.
AVAILABILITY
Tell us what your lab needs.
Request current availability for a lawful institutional, analytical or laboratory purpose. We confirm the exact presentation, price, batch and document state before any next step.
Exact presentation review
Jurisdiction and purpose check
Batch-document confirmation
No medical or human-use guidance
SELECTED PRODUCTTirzepatideCEL-P-TIR-001 · response after manual review
Tirzepatide: before you enquire
What exactly does the selected format mean?＋
The mg or IU value is the declared material content per vial; it is not the container volume. Your selected presentation and quantity are saved with your enquiry. The final price is confirmed in the response.
Which batch will be supplied?＋
The specific batch and its documents are confirmed in the response. Files shown here may be supplier reference samples; the current record does not yet contain a qualified CELLIVITY lot dossier.
When can it arrive in Thailand?＋
For confirmed local stock, the planned window is 2–3 working days in Thailand. Pattaya timing is agreed directly. Incoming or specially sourced products have a separate estimate, confirmed before a commitment.
Can I enquire about several products together?＋
Yes. Add each format and quantity to the cart, then send one availability enquiry. Your selected items are kept together for review.
CELLIVITY
Tirzepatide
CEL-P-TIR-001 · 10 mg
Tirzepatide is a synthetic, long-acting peptide that activates both GIP and GLP-1 receptors. Authorised tirzepatide medicines have been studied in large clinical programmes for defined metabolic indications; a catalogue vial does not automatically match an authorised finished medicine.
Dual GIP and GLP-1 receptor signalling in defined metabolic settings.
Other names
LY3298176 · tirzepatide
PubChem CID
156588324
Molecular formula
C225H348N48O68
Molecular weight
4813 g/mol
Peptide length
39 amino acids
Compound class
Synthetic dual GIP and GLP-1 receptor agonist
Follow the sources
Randomised clinical evidence supports authorised tirzepatide medicines for their labelled indications. It does not establish a general anti-ageing effect, and it cannot be transferred to an unverified bulk or catalogue presentation.
How much does each receptor contribute to measured metabolic effects?
How durable are changes in validated metabolic and body-composition markers?
Which longer-term safety signals matter in defined patient populations?
Lab documents
CELLIVITY lot review pending
No lab files received
Evidence for an authorised prescription product is not evidence for an unverified vial or a general longevity claim.
